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The pathway from gene activation in the nucleus to mRNA translation and decay at specific loca-
tions in the cytoplasm is both streamlined and highly interconnected. This review discusses how
pre-mRNA processing, including 50 cap addition, splicing, and polyadenylation, contributes to
both the efficiency and fidelity of gene expression. The connections of pre-mRNA processing to
upstream events in transcription and downstream events, including translation and mRNA decay,
are elaborate, extensive, and remarkably interwoven.688 Cell 136, 688–700, February 20, 2009 ª2009 Elsevier Inc.promoters are permanently engaged with Pol II initiation
complexes (Guenther et al., 2007; Muse et al., 2007) and may
generate 50 proximal abortive transcripts (Core and Lis, 2008;
Kapranov et al., 2007). Indeed, recent studies demonstrate
that short transcripts are generated in both the sense and anti-
sense directions from these pre-engaged polymerases (summa-
rized by Buratowski, 2008). The types of genes that possess
pre-engaged Pol II are particularly genes regulated at specific
development stages or inducible genes that need to rapidly
respond to new extracellular situations. By having Pol II already
plugged into the gene promoter, the complex process of uncov-
ering the gene from repressive chromatin structure and recruit-
ing the Pol II initiation complex from its component parts is
bypassed. Exactly what the molecular trigger is that switches
Pol II from abortive initiation into functional elongation mode is
still largely unknown (Figure 1). However, it has become evident
that pre-mRNA processing plays a critical role (Manley, 2002;
Orphanides and Reinberg, 2002; Sims et al., 2007).
The first RNA processing event to occur on the nascent tran-
script is 50 end capping. Three enzymatic activities, a triphospha-
tase, a guanyl transferase, and a methyl transferase, all act to
convert the pppA 50 terminus of the primary transcript to
7meGpppA (Shuman, 2001). The first two activities are present
on a single polypeptide in mammals but reside on separate
proteins, Ceg1 and Cet1, in yeast. All eukaryotes possess
a separate methyltransferase. Ceg1 and Cet1 are recruited to
the Pol II initiation complex once the CTD has become activated
by Ser5P formation through the action of TFIIH-associated cyclin
dependent kinase, Cdk7 (also known as Kin28 in S. cerevisiae;
Schroeder et al., 2000). Ceg1 directly associates with CTD
Ser5P, allowing it to act on nascent transcripts as soon as they
emerge from the elongating Pol II. Capping may well be a key
component of the switch that pushes Pol II from abortive early
elongation into fully processive elongation across the body of
the gene. Other components of this switch involve both negative
and positive elongation factors that may themselves be regu-
lated by phosphorylation dictated by cell signaling cascadesIn the 50 years since Crick’s proposition of the central dogma of
gene expression, there has been an explosion in our under-
standing of the steps involved in the flow of information from
DNA to RNA to protein. Whereas many early studies focused
on elucidating the machinery and mechanisms required for
each individual step in the process, a conceptual transformation
in the last decade came with the realization that gene activation in
the nucleus and later events in the cytoplasm, such as translation
and decay, are seamlessly integrated. In this review, we focus on
how pre-mRNA processing regulates both transcription in the
nucleus and the subsequent fate of an mRNA in the cytoplasm.
Nuclear Events
Before beginning this account, it is necessary to provide a brief
reminder of the critical impact of structural studies on RNA poly-
merase II (Pol II) for our understanding of this gene expression
‘‘superhighway.’’ Pol II has an overall globular structure with an
enlarged central active site wherein the DNA template is forced
apart as a single-stranded bubble (Cramer, 2004). Channels
into this active site allow nucleotide access and RNA exit. Below
the RNA exit channel lies a relatively unstructured protein
domain, the carboxyl terminus of the largest Pol II subunit (Mein-
hart et al., 2005). This carboxyl terminal domain (CTD) has a
simple heptad repeat structure, 26 repeats in Saccharomyces
cerevisiae (henceforth referred to as yeast), 52 in mammals,
and each repeat bears three serine residues that undergo revers-
ible phosphorylation during the transcription cycle (Egloff and
Murphy, 2008). Serine 5 phosphorylation (Ser5P) along the CTD
repeats is a hallmark of early transcription elongation, whereas
serine 2 phosphorylation (Ser2P) is associated with later-stage
elongation (Komarnitsky et al., 2000). Reference will be made
throughout our review to the key roles played by this structure.
Pol II: Poised for Action
A surprising discovery has emerged from genomic array analysis
in both single-cell eukaryotes such as yeast and differentiated
cells from multicellular organisms. This is that many gene
Figure 1. Transcription Elongation Is Coupled to Pre-mRNA Processing
Three stages of protein coding gene transcription are depicted. First, transcription of protein coding genes by RNA polymerase II (Pol II) involves an initial stage
where the polymerase is engaged with the gene promoter, but in a poised state. Productive elongation into the body of the gene has yet to commence. These
promoter-associated polymerases are shown to be associated with bidirectional transcription resulting in the production of short sense and antisense promoter
transcripts (Buratowski, 2008). Second, the initially poised polymerases switch to productive transcription elongation and read into the body of the gene. This
process is regulated by either developmental or cell signaling stimuli that remain largely uncharacterized. It is also associated with histone tail modifications
and a switch from Pol II C-terminal domain (CTD) serine 5 phosphorylation (Ser5P) to CTD Ser2P. The initial transcript is cotranscriptionally capped by replace-
ment of the triphosphate 50 terminus with a 7meGppp structure. Capping enzymes are recruited to Ser5P Pol II CTD. Finally, productive transcriptional elongation
is tightly coupled to cotranscriptional splicing which is facilitated by recruitment of splicing factors to the Pol II elongation complex. Nucleosomes are depicted as
brown discs. Pol II is depicted in purple with a DNA channel, CTD appendage, and exiting RNA transcript. H3K4Me3, histone H3 lysine 4 trimethylation.connected to the extracellular environment through membrane
receptors (Komarnitsky et al., 2000; Peterlin and Price, 2006).
Onewell-characterizedpositive factor inhighereukaryotes is the
heterodimeric protein PTEFb comprising the Cdk9 kinase and
associated cyclin T (also known as CTDK1 in yeast), which gener-
ates CTD Ser2P patterns on Pol II elongating into the body of the
gene (Peterlin and Price, 2006). PTEFb directly interacts with the
HIV-1 early gene product Tat through its cyclin T component (Mar-
cello et al., 2004). Tat is a key transcription elongation factor
responsible for switching HIV-1 provirus from latency to full tran-
scriptional activity. It does this by recognizing short, 50 terminal
abortive transcripts made during early proviral transcription. These
short transcripts generate an RNA hairpin called TAR that directly
interacts with Tat. Consequently, Tat recruits PTEFb and so effi-
cient elongation proceeds across the proviral genome, resulting
in full HIV-1 expression. Close parallels likely exist between the
HIV-1 proviral promoter and the above-mentioned large set of
genes that make short 50 terminal abortive transcripts. To date,
no host encoding protein factor analogous to Tat has been identi-fied. However, it is now appreciated that PTEFb itself is tightly
regulated by two negative factors, the small RNA 7SK and the
protein Hexim. These form an inhibitory trimeric complex with
Cdk9 effectively sequestering PTEFb away from transcription sites
in the nucleus (Nguyen et al., 2001). Again, the trigger that releases
Cdk9 from this repressive RNA protein complex is unknown but is
likely to be associated with phosphorylation of Hexim and Cdk9
through kinases sensitive to cell signaling cascades.
It Pays to be Flexible: Transcription and Chromatin
Conformation
Recent advances in microscopy have revealed that the nucleus
is highly dynamic, with both genes and their associated factors
showing remarkable mobility. Many inducible genes studied in
yeast relocate after activation, often juxtaposed with the nuclear
pore complex (NPC) (Akhtar and Gasser, 2007; Brown and
Silver, 2007). This effectively allows direct injection of the gene
transcript into the cytoplasm during the transcription process.
Interestingly, NPC-gene association often correlates with theCell 136, 688–700, February 20, 2009 ª2009 Elsevier Inc. 689
capacity of some inducible genes to display transcriptional
memory (Ahmed and Brickner, 2007). This term refers to the
ability of a gene to reactivate more rapidly after short-term
repression than when it has been repressed for longer periods.
During short-term repression, the gene remains associated
with the NPC so that when it is reactivated it switches into active
mode more rapidly. Several features of chromatin appear to be
required for transcriptional memory, including modified histone
deposition (Brickner et al., 2007) and chromatin remodeling
activities (Kundu et al., 2007). Also, cytoplasmic factors such
as Gal1 may play a role through contacts with the cytoplasmic
face of the NPC (Zacharioudakis et al., 2007). In contrast to the
above analysis of the yeast nucleus, studies on nuclear organiza-
tion in higher eukaryotes have led to the view that repressed
heterochromatin is often associated with the nuclear lamina.
This is a filamentous layer of protein that coats the nuclear
face of the inner membrane. However, locus boundary elements
that act to insulate active genes from repressed chromatin are
also membrane associated, but in this case associate with the
NPC and so may align active genes with the direct exit rout
from nucleus to cytoplasm (Akhtar and Gasser, 2007).
Another characteristic feature of activated genes is that they
switch their conformation when activated. In this case, a loop
structure is predicted to occur in which the promoter and termi-
nator of a gene are in close proximity (Ansari and Hampsey,
2005; O’Sullivan et al., 2004), as detected by the chromatin liga-
tion technique called 3C (Dekker et al., 2002). Gene loop forma-
tion brings into play the 30 terminal RNA processing mechanism.
30 cleavage and polyadenylation of pre-mRNA are dictated by
polyA signals that define the end of the mRNA. These signals
are recognized by a substantial cleavage/polyadenylation
protein complex (termed here polyA complex) that is recruited
to CTD Ser2P through direct CTD-interacting domains (CIDs)
as well as RNA binding domains (RBDs) that specifically recog-
nize the pre-mRNA polyA signals. Specific CIDs and RBDs
have been identified on individual polyA complex subunits (Bent-
ley, 2005; Proudfoot, 2004). Some components of the polyA
complex are also detected at gene promoters through interaction
with general transcription factors TFIID (Dantonel et al., 1997) and
TFIIB (Wu et al., 1999), presumably as a result of gene looping.
Thus, mutation of particular polyA complex components
(Ssu72 or Pta1) or the polyA signals themselves (particularly the
conserved mammalian polyA signal, AAUAAA) causes a break-
down in gene loop structure (Perkins et al., 2008; Singh and
Hampsey, 2007). Interestingly, CTD phosphorylation patterns
are also correlated with gene looping. Thus, gene loop structures
are lost when CTD Ser5P is prevented from forming by inactiva-
tion of Kin28 (O’Sullivan et al., 2004). Similarly, the Ssu72 protein
has CTD Ser5P phosphatase activity, again pointing to a require-
ment for a specific CTD phosphorylation state for the formation of
gene loops (Krishnamurthy et al., 2004). Although the functional
significance of gene loops remains to be established, two poten-
tial roles have been proposed. First, they may act to retain Pol II
once a full transcription cycle has completed, allowing it to be
rechanneled back to the promoter for another round of transcrip-
tion. In effect, Pol II need never release from its gene location as it
is either poised on the promoter or held in a gene loop structure.
Second, gene looping may play a role in gene surveillance. A first690 Cell 136, 688–700, February 20, 2009 ª2009 Elsevier Inc.or ‘‘pioneer’’ round of transcription may allow initial gene loop
formation to occur, provided that authentic polyA signals are
encountered by the elongating Pol II. This will then seal Pol II tran-
scription into a continuous productive mode (Figure 2).
The chromatin template is also modified during transcription in
part to enhance the efficiency of RNA synthesis and pre-mRNA
processing. CTD Ser5P acts to recruit the histone methylase
Set1, which trimethylates H3 lysine 4 (H3K4me3) over the
promoter proximal regions (Li et al., 2007). This may aid the
switch from nonproductive to productive transcriptional elonga-
tion. H3K4me3 marks also correlate with enhancement of
capping as well as the recruitment of splicing factors that act
on the emerging nascent RNA from the elongating Pol II complex
(Sims et al., 2007). As with NPC association, H3K4me3 marks
may extend through multiple rounds of transcription, affording
more rapid reactivation of transcription (Ng et al., 2003). Set2
similarly trimethylates H3K36 and in this case is recruited by
interaction with CTD Ser2P (Li et al., 2007; Shilatifard, 2006).
Together with other elongation factors such as PAF (Rosonina
and Manley, 2005), histone chaperones such as Spt6 (Yoh
et al., 2007) and FACT (Belotserkovskaya and Reinberg, 2004)
and the chromatin remodeler Chd1 (Sims et al., 2007),
H3K36me3 marks may facilitate more efficient elongation and
coupled splicing and 30 end processing (Figure 1B). Analysis of
the complex alternatively spliced mammalian gene CD44 also
revealed a role for the chromatin remodeling enzyme SWI/SNF
in Pol II elongation and associated splicing factor recruitment
to alternatively spliced introns (Batsche et al., 2006).
Splicing and Packaging the Transcript
during Pol II Elongation
The view that most pre-mRNA splicing occurs cotranscription-
ally appears to prevail for all eukaryotes. In vivo studies on
Figure 2. Transcription at the Nuclear Pore
Gene transcription by Pol II induces chromosomal movement, whereby the
gene may associate with the nuclear pore complex and in so doing may
form a looped conformation that brings the promoter and terminator regions
into close apposition. This conformational change is illustrated by showing
both the gene promoter and terminator regions and the packaged transcript
associated with the nuclear pore complex in a looped conformation. Such
a structure facilitates efficient nuclear export of messenger ribonucleoproteins
(mRNPs). The positions of nucleosomes and Pol II (as in Figure 1) are indicated
along with the packaged transcript (yellow balls depict packaging proteins).
spliceosome recruitment to actively transcribing genes suggests
that there is an ordered association of first U1 small nuclear RNA
protein complex (snRNP) to a newly formed 50 splice site tran-
script followed by U2 and U5 snRNPs when the rest of the intron
is synthesized (Gornemann et al., 2005; Lacadie and Rosbash,
2005). The spliceosome then forms and splicing of adjacent
exons ensues. Coupled in vitro transcription:splicing systems
further suggest that splicing factors are more efficiently assem-
bled on gene templates transcribed by Pol II than on those
transcribed by T7 phage RNA polymerase (Das et al., 2007).
Consequently, Pol II-derived transcripts are more efficiently
spliced. This was shown to be due to interaction of U1 snRNP
as well as splicing regulatory proteins with Pol II CTD (Das
et al., 2007). In the infrequent and relatively short introns of yeast,
the advantage of cotranscriptional splicing appears less evident.
However, with higher eukaryotes, the large number and often
substantial size (>10 kb) of introns suggests a significant benefit
for dealing with these large intronic transcripts as expeditiously
as possible. One way to achieve this may be to cotranscription-
ally cleave the intron sequence. It can then be degraded by
exonucleases, and so long as the adjacent exons are retained
on the polymerase elongation complex, then splicing can still
occur. Evidence that cotranscriptional cleavage of intronic
RNA can occur without affecting splicing has been demon-
strated in both yeast and mammalian experimental gene
systems (Dye et al., 2006; Lacadie et al., 2006). Furthermore,
natural examples of cotranscriptional intronic cleavage abound,
as abundant intronic pre-microRNAs are all likely to be excised
from introns cotranscriptionally, yet adjacent exons in the host
gene are still effectively spliced together (Kim and Kim, 2007;
Morlando et al., 2008).
The direct interplay between transcription and splicing has
been demonstrated in a number of studies. Over 20 years ago it
was realized that the presence of a promoter-proximal intron
increased transcription (Brinster et al., 1988). Subsequently, it
was shown that this effect acts at least in part to enhance Pol II
initiation (Furger et al., 2002). Pol II elongation is also enhanced
by factors that directly interact with the splicing apparatus.
Thus, the elongation factor TAT-SF1 interacts with U2 snRNP
(Kameoka et al., 2004), whereas SC35, which is directly associ-
ated with splicing, promotes more efficient elongation through
potential transcriptional pause sites (Lin et al., 2008). These pause
sites are often found spread throughout mammalian genes. The
connection between transcription and alternative splicing in
mammals has also been extensively studied. In general, it is clear
that where alternative splice sites compete for splicing the elon-
gation rate of Pol II can profoundly affect the alternative splicing
ratios. Pol II elongation rate is in part dictated by specific
promoters, which may act to recruit a more or less processive
Pol II complex (Figure 1C) (de la Mata et al., 2003).
As well as splicing the emerging Pol II transcript, the pre-mRNA
must also be immediately packaged into an expanding complex
with RNA binding proteins. In yeast, this packaging process is
brought about by the THO/TREX complex, a multicomponent
complex whose members variously function in transcription elon-
gation, transcript-dependent recombination, and mRNA export
(Iglesias and Stutz, 2008; Kohler and Hurt, 2007). Significantly,
transcript packaging connects with both ends of the nucleargene expression pathway. SAGA, a component of the Mediator
complex required for Pol II initiation, interacts with a second
complex TREX2 that in turn makes contacts with both the NPC
and THO/TREX. At the other end, THO/TREX interacts with
nuclear export factors such as Mex67, and these factors act to
anchor messenger ribonucleoproteins (mRNPs) to the NPC
(Kohler and Hurt, 2007). Nuclear surveillance pathways operate
at this stage to preclude unspliced or aberrantly spliced mRNPs
from exiting the nucleus. Mlp1 is a key factor associated with the
NPC that is closely connected with this process (Casolari and
Silver, 2004). Mutants lacking THO/TREX components show
accumulated gene 30 ends tethered to the NPC (Rougemaille
et al., 2008). Also, 30 cleavage/polyadenylation is impaired, and
these aberrant NPC:mRNP associations lead to transcript
destruction (Saguez et al., 2008). The principal enzyme respon-
sible for this and most other cellular RNA turnover is the exosome.
This multisubunit complex in its nuclear form contains two
30-50 exonucleases, Rrp6 and Dis3, which possess most of the
RNase activity (Schmid and Jensen, 2008).
A key function of pre-mRNA protein packaging is to prevent the
tendency of naked RNA released from the RNA exit channel from
invading the DNA duplex behind the elongating Pol II. Single-
strand RNA may directly base pair with the DNA template strand,
thereby forcing the sense DNA into an extended single-stranded
region (Figure 3). Such structures are referred to as R loops.
Evidence that R loop formation is indeed a deleterious conse-
quence of failed pre-mRNA packaging comes from studies in
both yeast and mammalian cells. Mutants in the THO/TREX
complex were often found to possess a marked DNA damage
phenotype (Aguilera and Klein, 1990). Further characterization
of specific genes in these affected mutant strains revealed elon-
gation defects that were rescued by overexpressing RNase H or
by incorporating ribozymes into the transcribed genes (Huertas
and Aguilera, 2003). Both of these experiments were interpreted
as indicating the presence of RNA:DNA hybrids that were pre-
dicted to slow down elongating Pol II. Similarly, the DNA damage
phenotype was explicable by formation of single-strand DNA,
Figure 3. Fates of Transcripts Generated by Pol II Elongation
Transcripts generated by Pol II elongation have several different immediate
fates. They may be cotranscriptionally packaged into messenger ribonucleo-
proteins (mRNPs) and after identification of splicing signals may also be
cotranscriptionally spliced. Alternatively, naked transcripts may invade the
DNA duplex behind elongating Pol II to form R loop structures. Here, the
template DNA strand is base paired with the transcript forcing the nontemplate
strand into a single-stranded conformation. Efficient mRNA packaging into
mRNP particles (yellow) restricts R loop formation.Cell 136, 688–700, February 20, 2009 ª2009 Elsevier Inc. 691
which is likely prone to mutagenesis. These data were confirmed
in higher eukaryotic cells where depletion of serine/arginine-rich
(SR) protein ASF/SF2 induced a DNA damage phenotype. The
presence of single-strand DNA was also detected in these
studies via bisulphite treatment of chromatin isolated from
these ASF/SF2-depleted cells. This chemical treatment modifies
single-strand dC residues to dU, which can then be detected by
DNA sequence analysis (Li and Manley, 2005). It should be noted
that pre-mRNA packaging has not been well characterized in
higher eukaryotes. However, it is possible that packaging
focuses on exonic regions that are thought to be covered
by heterogeneous ribonucleoproteins (hnRNPs), of which SR
proteins are one subclass (Bourgeois et al., 2004; Glisovic
et al., 2008). Intronic sequence may be only loosely packaged
with these RNA binding proteins so that R loop formation by
introns is principally avoided by their removal via splicing. Conse-
quently, the loss of splicing factors may be predicted to increase
R loop formation.
Together to the End: Pre-mRNA Processing
and Pol II Termination
The final stages in transcription of a gene occur when the poly-
merase reads through functional polyA signals, generating pre-
mRNA sequences recognized by the large polyA complex. As
mentioned above, this complex is recruited to elongating Pol II
in part through direct interaction of its components, especially
Pcf11 CID with the CTD Ser2P elongation mark (Bentley, 2005;
Licatalosi et al., 2002; Proudfoot, 2004). What happens next
varies depending on the type of Pol II transcribed gene as well
as between different eukaryotes. In yeast, the polyA complex
recognizes a series of somewhat redundant AU-rich RNA
elements through direct RNA recognition domains. Successful
association of polyA complex with these RNA sequences
promotes transcript cleavage at the polyA site by a specific
polyA complex component (CPSF-73 in higher eukaryotes or
Ydh1 in yeast; Mandel et al., 2006) and subsequent polyadeny-
lation of the newly formed 30 terminus by Pap1, also an integral
component of the polyA complex (Proudfoot, 2004). This polya-
denylation process facilitates mRNA release from the transcrip-
tion site and its ultimate export through the NPC to cytoplasmic
translation. However, the elongating Pol II itself requires further
RNA processing steps to facilitate its release from the gene
template. A complex of three polypeptides, one called Rtt103,
containing a CID with specificity for CTD Ser2P, is recruited to
the 30 product of 30 end cleavage. The other component of this
complex, Rat1, then acts together with its cofactor, Rai1, as
a potent 50-30 exonuclease (often referred to as a torpedo) to
degrade the nascent transcript still being generated by Pol II
elongating past the polyA signal (Kim et al., 2004). Rapid degra-
dation of this final Pol II transcript catching up with the elongating
Pol II appears to be the key signal that finally stops this molecular
juggernaut in its tracks.
In higher eukaryotes, a similar termination mechanism is likely
to occur. However, the substantial length of genes in higher
eukaryotes requires that additional termination signals in
30 flanking regions of genes cooperate with the polyA signal to
promote Pol II termination. For several characterized genes,
transcription pause sites positioned just after the polyA signal692 Cell 136, 688–700, February 20, 2009 ª2009 Elsevier Inc.act to slow down elongating Pol II (Gromak et al., 2006). This
effectively provides time for the 50-30exonuclease Xrn2 (Rat1
homolog) to attach to the 30 cleavage product and degrade the
downstream transcript, catching up with the elongating Pol II
(Kaneko et al., 2007; West et al., 2004). An interesting variation
on this termination process occurs in other Pol II-transcribed
genes. Here, although no pause sites are present downstream
of the polyA signal, another termination element exists that is
often positioned over 1 kb downstream. This termination
element is associated with rapid cotranscriptional cleavage of
the nascent transcript at the termination site (Dye and Proudfoot,
2001). This then provides immediate access of Xrn2 at this
30 flanking region position, and thereby Pol II is directly termi-
nated. Surprisingly, this termination process mediated by
cotranscriptional cleavage occurs so quickly that it precedes
cleavage at the polyA signal. In effect Pol II is released from
the DNA template with the pre-mRNA still anchored to the CTD
through contacts with the polyA complex. This final pre-mRNA
processing step may therefore occur posttranscriptionally but
still on a Pol II platform (West et al., 2008).
A further variation on Pol II termination has been uncovered by
studies in yeast. In this case, a second Pol II termination process
has been shown to operate involving yet another protein
complex containing Nrd1, Nab3, and Sen1 protein components.
This termination mechanism is employed by Pol II transcripts
derived from snRNA or small nucleolar RNA (snoRNA) genes
as well as the rapidly expanding repertoire of so-called cryptic
unstable transcripts (CUTs) (Arigo et al., 2006; Steinmetz et al.,
2001). A unifying feature of genes encoding snRNAs, snoRNAs,
and CUTs is that they are all relatively small transcription units.
The mechanism of this alternative Pol II termination process is
that Nrd1 interacts with Pol II, again through a CID domain. Inter-
estingly, this CID prefers CTD Ser5P, which neatly fits with the
action of this termination mechanism on shorter Pol II gene tran-
scripts (Gudipati et al., 2008; Vasiljeva et al., 2008). Termination
signals for this alternative mechanism are redundant GUAA/G
and UCUU sequences recognized by RNA binding domains of
Nrd1 and Nab3, respectively. An unresolved issue for this termi-
nation process is how these RNA signals remain accessible for
Nrd1 and Nab3 rather than being packaged into mRNPs by the
action of THO/TREX. Indeed, this leads to the question of how
promoter-proximal Nrd1-dependent termination is prevented in
regular protein coding genes that need to read through the whole
(usually longer gene) to the regular cleavage/polyA signals where
the polyA complex followed by Rat1 and associated factors
promote Pol II termination.
This final stage in pre-mRNA cotranscriptional processing is
both a key step in efficient gene expression and a critical control
point in preventing aberrant gene expression. When 30 process-
ing/polyadenylation is either inefficient or compromised by gene
mutation, then the nuclear exosome is recruited to rapidly
degrade the unwanted transcript. Interestingly, the Nrd1 termi-
nation pathway achieves this process by directly recruiting the
exosome through interaction with Nrd1 (Vasiljeva and Buratow-
ski, 2006). In effect, Nrd1-mediated Pol II termination is associ-
ated with rapid transcript degradation. snRNAs and snoRNAs
escape this exosome-mediated degradation by protecting the
mature RNAs cotranscriptionally with specific RNA binding
proteins (Morlando et al., 2004). In contrast, CUTs have no such
protection and are rapidly degraded. It should also be mentioned
that the above described mechanisms of Pol II termination must
somehow be reconciled with the phenomena of gene loop
formation and gene 30 end association with the NPC. Both of
these mechanisms require functional 30 end processing and
termination signals. It therefore seems plausible that Pol II termi-
nation does not simply release Pol II into the nucleoplasm but
rather that terminated Pol II is retained at specific nuclear loca-
tions that allow its rapid reassociation with gene promoters.
Cytoplasmic Events
In addition to these interconnected events in the nucleus, there
are also well-documented connections between nuclear
processes and downstream cytoplasmic events. This influence
is mediated by the repertoire of proteins that, together with the
mRNA, make up the mRNP (Glisovic et al., 2008; Moore, 2005).
Many mRNP proteins first encounter the transcript as it emerges
from Pol II in the nucleus and then accompany the processed
mRNA out to the cytoplasm (Figure 4). mRNP proteins can be
thought of as adaptors that add functionality to a transcript by
interfacing with a wide variety of cellular machineries. Some of
these adaptors recognize particular structures (such as the
50 cap or the 30 polyA tail) or short consensus sequences, whereas
others become associated primarily as a consequence of the
mRNA manufacturing process. Of particular note is the splicing
history of an mRNA, which can influence almost every stage of
its subsequent metabolism, including how quickly and efficiently
it is exported from the nucleus, whether it is correctly localized in
the cytoplasm, how efficiently it is taken up by the translation
machinery, and whether it is a target for nonsense-mediated
mRNA decay (NMD) (Giorgi and Moore, 2007; Le Hir et al., 2003).
TheExon JunctionComplex andOtherMolecularGraffiti
To date a surprising number of mRNP proteins have been shown
to exhibit some degree of splicing dependence in their associa-
tion with mRNA (Merz et al., 2007). One of the most extensively
studied is the exon junction complex (EJC), a set of proteins
stably deposited on spliced mRNAs about 20 nucleotides
upstream of exon-exon junctions (Le Hir et al., 2000). That
such a complex might exist was initially intimated by the then
unexpected observation that recognition of termination codons
as premature in mammalian mRNAs depends on their spatial
relationship to the 30-most exon-exon junction. This suggested
that the splicing machinery was capable of tagging splice junc-
tions with some sort of mark that could signify to downstream
processes the positions at which introns had resided in the orig-
inal transcript (Thermann et al., 1998; Zhang et al., 1998). We
now know that this molecular tag consists of a tri- or tetrameric
protein core stably deposited on the splice donor exon at a late
stage in the splicing process (Le Hir and Andersen, 2008). This
core accompanies the mRNA to the cytoplasm, where EJCs
within open reading frames (ORFs) are removed by the first or
‘‘pioneer’’ round of translation (Dostie and Dreyfuss, 2002;
Lejeune et al., 2002). In both the nucleus and cytoplasm, other
factors that associate more dynamically interface with the EJC
core to mediate its widespread effects on mRNA metabolism
(Tange et al., 2004).The mystery of how the EJC core remains stably bound to
spliced mRNAs without benefit of either covalent attachment or
significant structure or sequence specificity was solved by iden-
tification of the DEAD-box protein eIF4AIII (DDX48) as the main
RNA anchoring constituent (Shibuya et al., 2004). DEAD-box
proteins, a subgroup of the DExH/D-box family of RNA-depen-
dent ATPases, are often presumed to function as RNA or RNP
remodelers on the basis of their sequence similarity to the SF2
family of DNA helicases (Cordin et al., 2006; Jankowsky and Fair-
man, 2007). But within the EJC core, inhibition of eIF4AIII ATPase
activity by its binding partners Y14 and Magoh locks eIF4AIII into
a stable RNA binding configuration. An additional core protein,
MLN51, increases the affinity of eIF4AIII for RNA, which is other-
wise low (Ballut et al., 2005). Thus, as a component of the EJC,
eIF4AIII functions not as a helicase or translocase, but rather as
a regulatable, sequence-independent RNA binding protein.
This ‘‘clothes peg’’-like activity of eIF4AIII both preserves the
synthetic history of the mRNA and adds functionality to the
mRNP as a binding platform for other key regulatory factors.
Intriguingly, two other DEAD-box proteins, DDX3 and DDX5/
p68, were recently shown to associate with spliced mRNAs in
a manner similar to the EJC (that is, their association required
both splicing and the EJC binding region about 20 nucleotides
upstream of the splice junction) (Merz et al., 2007). Like the EJC
proteins, DDX3 and DDX5/p68 have been functionally implicated
in diverse processes including transcription, splicing, mRNA
export, translation, and mRNA decay (Fuller-Pace and Ali,
2008; Rosner and Rinkevich, 2007). Currently, it is unknown
whether these new DEAD-box proteins act in concert with
eIF4AIII-containing EJCs or whether they are themselves
anchors for alternate EJC-like complexes. Supporting the latter
notion is evidence that the recruitment and/or function of some
Figure 4. Splicing Factors Contribute to mRNP Export
Messenger ribonucleoprotein (mRNP) components associated with splicing
contribute to mRNA export in mammalian cells. Both the THO/TREX complex
and the exon junction complex (EJC) are loadedonto mRNAs asa consequence
of splicing. Splicing-dependent hypophosphorylation of shuttling SR proteins
may also stabilize their association with mRNA. Both hypophosphorylated
SR proteins and the THO/TREX complex can act as export adaptors via inter-
action with the nuclear export receptor NXF1/TAP. Positioning of the THO/
TREX complex near the 50 cap may assist mRNAs in exiting the nucleus
50 end first to more efficiently engage the cytoplasmic translation machinery.Cell 136, 688–700, February 20, 2009 ª2009 Elsevier Inc. 693
splicing-dependent mRNP proteins can occur independently of
eIF4AIII (Gehring et al., 2005; Zhang and Krainer, 2007).
Other mRNP components with direct links to splicing include
the shuttling serine/arginine-rich (SR) proteins. These proteins
join pre-mRNAs cotranscriptionally and generally recognize
short consensus sequences by way of one or two N-terminal
RNA recognition motifs (RRMs). A characteristic C-terminal
domain rich in arginine/serine dipeptides (the RS domain) can
serve either as a protein-protein or a protein-RNA interface and
is subject to dynamic serine phosphorylation (Bourgeois et al.,
2004; Huang and Steitz, 2005). In contrast to the EJC, which
has no apparent role in splicing (Shibuya et al., 2004; Zhang
and Krainer, 2007), SR proteins are key players in recruiting the
splicing machinery to constitutive splice sites, in spliceosome
assembly and in directing alternative splicing (see Review by
M.C. Wahl, C.L. Will, and R. Luhrmann on page 701 of this issue).
Dependent on their binding site context within a particular tran-
script (that is, intronic or exonic), their posttranslational modifica-
tion state, and the levels of other splicing regulators in that cell
type, various SR proteins can act to either enhance or inhibit
splicing of nearby exons and splice sites (Bourgeois et al.,
2004). Upon completion of pre-mRNA processing, those SR
proteins bound to exonic sequences can then accompany the
mRNA to the cytoplasm where, like the EJC, they can direct
mRNA localization, translation, and decay (Huang and Steitz,
2005). Further paralleling the EJC, several SR proteins have
recently been shown to exhibit some degree of splicing-depen-
dent mRNP recruitment when splicing is uncoupled from tran-
scription in vitro (Merz et al., 2007).
Splicing and Subcellular mRNA Localization
As discussed above, a key mediator of nuclear mRNA export is
the THO/TREX complex. This assemblage principally consists of
the tetra- (budding yeast) or pentameric (metazoans) THO
complex, which functions in transcription elongation and
transcript-dependent recombination, plus the mRNA export
factors Yra1 (REF/Aly in mammals) and Sub2 (UAP56 in
mammals). Yra1 is an RRM-containing RNA binding protein
that bridges the mRNA to the export receptor Mex67 (NXF1/
TAP in mammals), whereas Sub2 is a DEAD-box protein that
also functions in spliceosome assembly (Iglesias and Stutz,
2008; Kohler and Hurt, 2007; Shen et al., 2008). In budding yeast,
where most genes lack introns, the THO/TREX complex is
closely associated with the transcription machinery, where it is
thought to coat the length of intronless transcripts with Yra1
and Sub2 as the RNA emerges from the elongating polymerase
(Abruzzi et al., 2004). In mammals, however, where most genes
contain multiple introns, REF/Aly and UAP56 appear to be
recruited more as a consequence of splicing than of transcrip-
tion. In vivo, both proteins colocalize with transcription sites for
intron-containing genes but not with mutant versions incapable
of splicing (Custodio et al., 2004). Further, when uncoupled
from transcription in vitro, THO/TREX complex recruitment is
strongly 50 cap and splicing dependent (Cheng et al., 2006;
Masuda et al., 2005). Although REF/Aly and UAP56 were origi-
nally thought to be recruited via the EJC, more recent evidence
indicates that these proteins primarily reside on the region imme-
diately downstream of the cap, tethered there by an interaction694 Cell 136, 688–700, February 20, 2009 ª2009 Elsevier Inc.between REF/Aly and the nuclear cap binding protein CBP80
(Cheng et al., 2006). Thus, unlike the EJC, which is presumably
deposited at every exon-exon junction, the mammalian THO/
TREX complex appears to associate most strongly with the
50-most exon of spliced mRNAs. These findings nicely reconcile
a long-standing conundrum that the cap facilitates the export of
spliced mRNAs but is of lesser consequence for intronless
mRNAs (Masuyama et al., 2004). Whereas REF/Aly is not essen-
tial for bulk mRNA export in metazoans (Gatfield and Izaurralde,
2002; Longman et al., 2003), its recruitment via splicing can
clearly increase the speed and efficiency of the export process
(Luo and Reed, 1999; Valencia et al., 2008). Furthermore, the
positioning of the THO/TREX complex at the 50-end of spliced
mRNAs has been proposed to impart directionality so that
mRNAs emerge from the nuclear pore 50-end first to more effi-
ciently engage the translation machinery (Valencia et al., 2008).
In addition to the THO/TREX complex, SR and SR-like proteins
can also function as mRNA export adaptors (Huang and Steitz,
2005). As with REF/Aly, the shuttling SR proteins SRp20, 9G8
and ASF/SF2 can all serve as mRNP binding sites for the general
export receptor NXF1/TAP. Intriguingly, NXF1/TAP preferentially
interacts with the shuttling SR proteins in their hypophosphory-
lated state, the state thought to be active for mRNA export.
Conversely, SR proteins are initially recruited to pre-mRNAs for
splicing in a hyperphosphorylated state, and become partially
dephosphorylated as the splicing reaction proceeds. Thus, it
has been suggested that the export competence of the spliced
mRNP is signaled by the phosphorylation status of its bound
SR proteins (Huang and Steitz, 2005; Kohler and Hurt, 2007).
Given recent evidence that some SR proteins (including 9G8
and ASF/SF2) exhibit splicing-dependent mRNP recruitment
in vitro (Merz et al., 2007), perhaps their partial dephosphoryla-
tion during splicing also serves to stabilize their interaction with
exonic regions, enabling them to remain associated with the
spliced mRNP. After export, rephosphorylation of the SR
domains is thought to trigger their release from the mRNA and
facilitate their reimport into the nucleus (Huang and Steitz,
2005; Kohler and Hurt, 2007). Such a cycle of nuclear dephos-
phorylation-dependent mRNA and export receptor binding and
cytoplasmic rephosphorylation-dependent mRNA and export
receptor release has been well documented for the SR-like
mRNA export adaptor Npl3 in budding yeast (Gilbert and
Guthrie, 2004).
Once released from the nuclear pore, many mRNAs are further
localized to particular sites in the cytoplasm (Besse and Ephrussi,
2008; see Review by K.C. Martin and A. Ephrussi on page 719 of
this issue). A recent genome-wide study of over 2300 mRNAs in
Drosophila embryos revealed that a remarkable 71% of these
exhibited a distinct localization pattern. Further, tight colocaliza-
tion of encoded proteins with their mRNAs suggests that subcel-
lular protein localization patterns are largely driven by mRNA
localization (Lecuyer et al., 2007). One localized Drosophila
mRNA that has been particularly well-studied is oskar. oskar
mRNA is produced by nurse cell nuclei and imported into the
developing oocyte, where it is subsequently localized to the
posterior pole. Restricted translation of oskar protein at this
pole is crucial for early pattern formation in the developing
embryo. Among factors required for oskar mRNA transport are
the EJC core factors eIF4AIII, Tsunagi, Mago Nashi, and Barentz
(the Drosophila orthologs of Y14, Magoh, and MLN51, respec-
tively) (Palacios, 2002; Palacios et al., 2004), and splicing of the
first intron in oskar pre-mRNA is essential for subsequent
mRNA localization (Hachet and Ephrussi, 2004). Consistent
with this, all four EJC core factors initially accumulate with oskar
at the posterior pole (Palacios, 2002; Palacios et al., 2004).
Because oskar’s first intron is within the ORF, its associated
EJC is subject to removal by the pioneer round of translation
(Dostie and Dreyfuss, 2002; Lejeune et al., 2002). This indicates
that oskar experiences no pioneer round until it reaches its final
destination, consistent with the idea that mRNAs are maintained
in a translationally quiescent state during the localization process
(Besse and Ephrussi, 2008; Giorgi and Moore, 2007). What
remains to be resolved is the exact role of the EJC in oskar local-
ization—is it necessary for translational silencing, or does it
participate more directly as part of the transport machinery?
Also, oskar is the only mRNA to date whose localization is known
to have a clear splicing dependence. Therefore, whether the EJC
is a general player in mRNA localization remains to be seen.
Splicing Makes for Better Translation
Another well-documented effect of splicing on cytoplasmic
mRNA metabolism is enhanced translational efficiency (Le Hir
et al., 2003; Le Hir and Seraphin, 2008). That is, spliced mRNAs
on average yield more protein molecules than do otherwise iden-
tical cDNA transcripts. This is because spliced mRNAs more effi-
ciently engage the translation machinery during the pioneer
round of translation, such that a greater percentage of spliced
mRNA molecules end up associated with polysomes than do
unspliced mRNAs. One advantage of this phenomenon is that
it favors the translational uptake of newly made mRNAs that
are still associated with their nuclear-acquired proteins over
older transcripts that have already been translated and have
therefore lost these components. This effect may shorten the
lag time between transcriptional induction and protein expres-
sion, which could be particularly important for signal transduc-
tion pathways triggering new mRNA synthesis.
A recent flurry of papers has begun to sort out the previously
mysterious means by which the EJC serves to enhance transla-
tion initiation (Figure 5A). One proposed mechanism involves
a bridge between the EJC and the 48S preinitiation complex
mediated by the Y14:Magoh binding protein PYM (Diem et al.,
2007). Another is through EJC-dependent recruitment of the
40S ribosomal protein S6 kinase 1 (S6K1) (Ma et al., 2008).
S6K1 is a central player in the TOR signaling cascade, a major
regulator of protein expression related to cell growth (Bhaskar
and Hay, 2007). When activated by the TOR pathway, S6K1
enhances translation initiation by activating stimulatory and inac-
tivating inhibitory factors bound at and around the 50 cap of TOR
target mRNAs. New work from Blenis and colleagues has re-
vealed that activated S6K1 is specifically recruited to newly
synthesized mRNAs via EJC-bound SKAR (a S6K1 target),
where it promotes the pioneer round of translation (Ma et al.,
2008). Supporting this idea that the TOR pathway is a general
player in the preferential translation of mRNPs still associated
with their nuclear-acquired factors, Ca´ceres and coworkers
recently demonstrated that the shuttling SR protein ASF/SF2also enhances translation initiation via recruitment of S6K1 (Mi-
chlewski et al., 2008). Like the EJC, ASF/SF2 had previously
been shown to enhance translation of bound mRNAs, thereby
providing another link between splicing and translation (Sanford
et al., 2004). In addition to S6K1, ASF/SF2 also interacts with
PP2A phosphatase, an antagonist of S6K1-dependent phos-
phorylation. An attractive model, which remains to be tested, is
that ASF/SF2 plays a dual role in promoting translation initiation
by both recruiting activated S6K1 and inhibiting factor dephos-
phorylation by PP2A (Michlewski et al., 2008).
Splicing and NMD: Not All Nonsense
One of the strongest connections between nuclear and cyto-
plasmicmRNA metabolism is the linkbetween pre-mRNA splicing
and nonsense-mediated mRNA decay (NMD). NMD is a transla-
tion-dependent degradation pathway specifically targeting
mRNAs wherein the first inframe stop codon is in a poor context
for translation termination. In mammals, the presence of one or
more EJCs 50 or more nucleotides downstream of such a stop
codon can greatly enhance the efficiency of NMD (Chang et al.,
2007; Stalder and Muhlemann, 2008). Thus, in the vast majority
of mammalian genes, the constitutive stop codon is either in the
last exon or within 50 nucleotides of the final exon-exon junction
(Nagy and Maquat, 1998). The means by which the EJC enhances
NMD is by serving as a binding platform for the NMD-specific
factors Upf2 and Upf3. The central player in this process is the
RNA helicase Upf1, which forms a surveillance or SURF (Smg1-
Upf1-eRF1-eRF3) complex with its cognate kinase, Smg1, and
Figure 5. Splicing Factors Regulate Translation Initiation
Effects of splicing-dependent mRNP components on translation initiation
(A) Both the exon junction complex (EJC) and ASF/SF2 bound to spliced
mRNA can promote the first or ‘‘pioneer’’ round of translation by recruiting
40S ribosomal protein S6 kinase 1 (S6K1), a component of the TOR signaling
cascade. For the EJC pathway, this is accomplished via the EJC-interacting
protein SKAR. ASF/SF2 can also promote translation initiation by inhibiting
the S6K1 antagonist PP2A phosphatase.
(B) When an EJC is located more than 50 nucleotides downstream of a prema-
ture termination codon (PTC), interaction between the EJC and SURF complex
causes phosphorylation of Upf1, which then inhibits additional rounds of trans-
lation by an interaction with the translation initiation factor eIF3.Cell 136, 688–700, February 20, 2009 ª2009 Elsevier Inc. 695
Figure 6. Splicing Patterns of Various NMD
Substrates
(A) One function of nonsense mediated decay
(NMD) is to eliminate mutant mRNAs containing
a truncated open reading frame (red bar).
(B) Examples of alternative splicing patterns used
to regulate gene expression via NMD. At low
concentrations of the encoded protein, the default
splicing pattern (top) results in a full-length open
reading frame and stable protein expression.
However, when the encoded protein concentra-
tion becomes too high, it alters splicing of its
own message (bottom) to include a PTC. Inclusion
of a ‘‘poison exon’’ that introduces a PTC is typical
of SR proteins, which are usually splicing activa-
tors, whereas exon skipping is typical of heteroge-
neous ribonucleoproteins (hnRNPs), which tend to
act as splicing repressors.
(C) The mammalian Arc gene contains two introns
downstream of its normal stop codon, making the
constitutively spliced mRNA a natural NMD target.696 Cell 136, 688–700, February 20, 2009 ª2009 Elsevier Inc.NMD provides an important clean up and quality control function.
Additionally, by eliminating unproductively spliced mRNAs, NMD
may allow organisms to continually sample new alternative splice
forms, some of which could have beneficial activities on an
evolutionary timescale.
Yet, this clean up and mRNA quality control function is far from
NMD’s sole role in the cell. Recent evidence indicates that NMD
is also a key player in the posttranscriptional regulation of wild-
type genes (Stalder and Muhlemann, 2008). For example,
numerous pre-mRNA splicing factors appear to regulate their
own expression by targeting their mRNAs to NMD when intracel-
lular protein concentrations become too high. This is typically
accomplished by altering the pre-mRNA splicing pattern, such
that the alternatively spliced mRNA carries an EJC downstream
of the stop codon and so is an NMD target (Figure 6B) (McGlincy
and Smith, 2008). In this new twist on a classic self-regulatory
feedback loop, the combination of alternative splicing and
NMD functions to maintain cellular protein concentrations within
an optimal range. Indeed, some of the more global alternative
splicing changes observable in cells wherein NMD has been
inhibited most likely result from pleiotropic effects induced by
misregulation of key alternative splicing factors in this way.
Other mRNAs are natural NMD targets due to constitutively
spliced introns in their 30 UTRs (Figure 6C). One such example is
Arc/Arg3.1 (activity-regulated cytoskeletal-associated protein/
activity-regulated gene 3.1), an immediate early gene whose
expression is rapidly induced upon neuronal activity. Arc protein
serves as a key modulator of multiple forms of neuronal plasticity
and is essential for the consolidation of long-term memory. Upon
transcriptional induction, Arc mRNA is trafficked to dendrites
where it is locally translated at activated synapses. In mammals,
the Arc gene has two conserved introns in its 30 UTR, and Arc
mRNA exhibits translation-dependent decay via the Upf1
pathway. Interference with EJC deposition leads to increased
levels of Arc protein at synapses and quantifiable changes in
synaptic scaling (Giorgi et al., 2007). Arc thus illustrates another
use of NMD to regulate gene expression. Because NMD
substrates are stable as long as they remain translationallythe release factors eRF1 and eRF3 bound to the ribosome stalled
at the stop codon. Contact between the SURF complex and Upf2
bound to a downstream EJC triggers phosphorylation of Upf1 by
SMG1 (Kashima et al., 2006). By a mechanism yet to be eluci-
dated, phosphorylated Upf1 promotes recruitment of the RNA
decay machinery, thus targeting the bound RNA for rapid degra-
dation. But, even before the mRNA is eliminated, phosphorylated
Upf1 apparently inhibits further rounds of translation by prevent-
ing conversion of 48S preinitiation complexes into 80S ribosomes
through interaction with eIF3 (Isken et al., 2008). Thus, when posi-
tioned downstream of a stop codon, the EJC has the opposite
effect on protein expression from when it is situated in the
50 untranslated region (UTR) or ORF (Figure 5B). Conversely, the
efficiency of NMD is also affected by the efficiency of such
upstream splicing events (Gudikote et al., 2005). Consistent
with their roles in facilitating translation of newly synthesized
mRNAs (see above), both the EJC and ASF/SF2 have been impli-
cated in this additional splicing-dependent enhancement of NMD
(Gudikote et al., 2005; Zhang and Krainer, 2004). Indeed, it has
been suggested that efficient splicing and EJC deposition
evolved to enhance both protein production and mRNA surveil-
lance (Gudikote et al., 2005).
NMD was originally described as a means for eliminating
mutant or malformed mRNAs containing unnatural or premature
termination codons (PTCs) (Figure 6A). Such mRNAs are
produced from mutant alleles containing a frameshift or
nonsense codon produced for example by unproductive rear-
rangements at V(D)J loci in B and T cells or from errors introduced
into individual mRNA molecules by the transcription and pre-
mRNA processing machineries (Chang et al., 2007; Isken and
Maquat, 2007). Indeed, such mutant alleles account for up to
30% of all human hereditary disorders (Holbrook et al., 2004).
In some cases, such as the unc-54 myosin heavy chain gene in
the nematode C. elegans, it has been well documented that the
C-terminally truncated proteins encoded by PTC-containing
alleles can exert dominant negative effects if the NMD pathway
is genetically disabled (Pulak and Anderson, 1993). Thus, by sup-
pressing expression of potentially deleterious truncated proteins,
quiescent, such mRNAs can accumulate at specific sites in the
cytoplasm where they may be poised for rapid response to
external stimuli. Upon translational activation, rapid NMD onset
could quickly curtail protein synthesis, resulting in a tightly
controlled burst of the desired product. Indeed, given that
mammalian NMD is thought to occur coincident with the pioneer
round of translation (Isken and Maquat, 2007), constitutive NMD
targets potentially encode just a single polypeptide prior to their
demise. Thus, unlike the cases above where NMD of alternatively
spliced mRNAs is exploited to lower mRNA and protein levels in
bulk, activation and degradation of constitutive NMD targets
may serve as a means to produce tightly controlled bursts of
protein at distinct subcytoplasmic locations (Giorgi et al., 2007).
Conclusion
This review attempts to chart the amazingly complex process of
gene expression in eukaryotes. This begins with pre-mRNA
synthesis from an active gene in nuclear chromatin and ends
with degradation of the mature mRNA at often distant sites of
protein synthesis in the cytoplasm. It is increasingly clear that
enormous trouble is taken to both streamline this process for
productive gene expression and to quickly eliminate erroneous
mRNAs that might otherwise result in molecular disaster. At
every point along the way, multifunctional proteins and RNP
complexes facilitate communication between upstream and
downstream steps, providing both feedforward and feedback
information essential for proper coordination of what can only
be described as an intricate and astonishing web of regulation.
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